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Abstract
Innate immune sensing of viral nucleic acids triggers type I interferon (IFN) production, which 
activates interferon-stimulated genes (ISGs) and directs a multifaceted antiviral response. ISGs 
can also be activated through IFN-independent pathways, although the precise mechanisms remain 
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elusive. Here we found that the cytosolic exonuclease Trex1 regulates the activation of a subset of 
ISGs independently of IFN. Both Trex1−/− mouse and TREX1-mutant human cells express high 
levels of antiviral genes and are refractory to viral infections. The IFN-independent activation of 
antiviral genes in Trex1−/− cells requires STING, TBK1 and IRF3 and IRF7. We also found that 
Trex1-deficient cells display expanded lysosomal compartment, altered subcellular localization of 
the transcription factor EB (TFEB), and reduced mTORC1 activity. Together, our data identify 
Trex1 as a regulator of lysosomal biogenesis and IFN-independent activation of antiviral genes, 
and shows dysregulation of lysosomes can elicit innate immune responses.
Vertebrates are constantly facing challenges from pathogenic microbes that introduce a 
variety of microbial proteins and nucleic acids into the host cell. To counter this, eukaryotic 
cells express many different pattern-recognition receptors (PRRs) that detect microbial 
pathogen-associated molecular patterns (PAMP), which then activate antiviral interferon 
(IFN) and proinflammatory responses1. Mammalian PRRs include Toll-like receptors 
(TLRs), RIG-I-like receptors (RLRs), NOD-like receptors (NLRs), C-type lectin receptors 
(CLRs), and an emerging category of cytosolic DNA receptors2. In the case of viral 
infection, viral nucleic acids are the major PAMP detected by the host innate immune 
receptors, which include RLRs and DNA receptors in the cytosol and a subfamily of TLRs 
that localize to the endosomal membrane3. The central hub for cytosolic DNA sensing is the 
endoplasmic reticulum (ER) membrane protein STING (also known as MITA, MPYS or 
ERIS)2. A number of proteins have been proposed to detect double-stranded DNA in the 
cytosol and signal through STING, such as DAI, IFI16 and DDX414–6. STING can also 
directly recognize c-di-GMP, which is usually associated with bacterial infection and 
activates IFN expression7. Although IFN plays a major role in controlling viral infections, 
IFN-independent pathways also exist and are vital for antiviral defense. For example, 
STING can activate STAT6 independently of the IFN pathway; and activated STAT6 
induces chemokine expression that primes adaptive immune responses8. Infection with 
enveloped viruses also triggers an IFN-independent pathway that involves the direct 
activation of a subset of IFN stimulatory genes (ISG) by IRF39. A recent study of MAVS-
mediated innate immune responses to RNA viruses demonstrated that IFN-independent 
induction of antiviral genes occurs rapidly after infection and is functionally important for 
controlling viral replication before the onset of more robust and sustained IFN activation10.
Innate immune sensing pathways are carefully designed to distinguish self- versus non-self 
ligands, either by spatial separation (e.g. TLR7 and TLR9 reside in endosomes which are 
devoid of host nucleic acids), or by stringent ligand specificity (e.g. TLR9 recognizes CpG-
containing DNA in bacteria; RIG-I recognizes 5′-ppp-containing RNA in viruses). However, 
how cytosolic DNA sensing pathways distinguish host and viral DNA remains unclear. We 
have previously identified Trex1, an exonuclease that resides on the ER, as a negative 
regulator of innate immune sensing of cytosolic HIV DNA. In Trex1−/− mouse embryonic 
fibroblasts or human CD4+ T cells and macrophages in which Trex1 was depleted by RNAi, 
cytosolic HIV DNA accumulated and triggers IFN through the STING-TBK1-IRF3 
pathway11. These findings and other studies12 suggest that cells rely on negative regulatory 
mechanisms such as Trex1 to keep cytosolic DNA sensing pathways in check.
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Trex1 deficiency has been implicated in the pathogenesis of autoimmunity. TREX1 
mutations in humans are associated with a spectrum of autoimmune and inflammatory 
phenotypes including Aicardi-Goutières syndrome (AGS, an inflammatory brain disease that 
mimics the symptoms of congenital viral infection 13,14), systemic lupus erythematosus 
(SLE), familial chilbain lupus (FCL) and retinal vasculopathy with cerebral leukodystrophy 
(RVCL)15–17. TREX1 mutations were found in up to 2% of SLE patients with an extremely 
high odds ratio (OR=25)18, representing one of the highest disease risk recorded for a single 
susceptibility gene in complex polygenic SLE14. Studies using Trex1−/− mice revealed that 
Trex1−/− cells accumulate cytosolic ssDNA that might be derived from DNA repair in the 
nucleus or from endogenous retroelements19,20. Recent genetic evidence demonstrated that 
the STING-mediated DNA sensing pathway is essential for the pathogenesis of autoimmune 
disease in Trex1−/− mice12. Initiation of IFN expression is only detected in a subset of non-
hematopotic cells in Trex1−/− mice, raising the question of what happens to the majority of 
other cells that also lack Trex1 function. We also wondered whether Trex1 inhibits IFN 
responses to other viruses besides HIV, and/or if the mere loss of Trex1 function in a cell 
would elicit innate immune responses and establish an antiviral state?
In this study, we found that Trex1-deficient or mutant cells display broad antiviral activity 
against many RNA viruses. The antiviral activity comes from elevated expression of ISGs in 
cells that lack Trex1 function, and is mediated through an IFN-independent signaling 
pathway that involves STING-TBK1-IRF3-IRF7. We also found that Trex1 regulates 
lysosomal biogenesis through TFEB and mTORC1 pathway, and provided evidence that 
dysregulation of lysosomes elicits innate immune response.
RESULTS
Impaired VSV replication in Trex1 deficient cells
To investigate whether Trex1 is involved in the IFN response to RNA viruses, we infected 
wild-type (WT) and Trex1−/− MEFs with vesicular stomatitis virus (VSV, Indiana strain), a 
negative stranded RNA virus, with VSV-G pseudotyped HIV11, or with a mock infection, 
and measured levels of IFN-β mRNA 24 h post infection (hpi). As previously reported11, 
mock-infected WT and Trex1−/− cells did not express detectable levels of IFN-β mRNA, 
and HIV infection only stimulated IFN-β mRNA expression in Trex1−/− cells, but not in WT 
cells. In contrast, VSV infection stimulated strong IFN-β mRNA expression in both WT and 
Trex1−/− cells at similar levels (Fig. 1a), suggesting that Trex1 does not regulate the Type I 
IFN response to VSV. However, VSV replication was severely impaired in Trex1−/− cells 
compared to WT, even though IFN-β induction was indistinguishable between the two cell 
types (Fig. 1b–d). Specifically, mRNA levels of two major forms of VSV RNA, G and M, 
were reduced to 12% and 7% (of WT), respectively, in Trex1−/− as compared to in WT cells 
(Fig. 1b). We also detected markedly reduced amounts of VSV proteins in Trex1−/− as 
compared to in WT cells, using two different multiplicities of infection (MOI, 2 and 10) 
(Fig. 1c). VSV titers from infected Trex1−/− cells were also reduced compared to WT (Fig. 
1d). To better quantify and visualize VSV replication, we infected WT and Trex1−/− cells 
with VSV-PeGFP, in which eGFP was fused in-frame to the VSV P protein that is usually 
associated with viral RNA replication foci in the cell21. We observed reduced VSV-PeGFP 
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replication (14% of WT) in Trex1−/− cells compared to WT cells by fluorescence-activated 
cell sorting (FACS) analysis (Fig. 1e).
Consistent with our FACS data, fluorescent microscopy analysis of infected WT cells 
revealed bright replication foci marked by PeGFP, whereas very little green fluorescent 
signal was detected in VSV-PeGFP infected Trex1−/− cells (Fig. 1f). We also infected bone 
marrow-derived macrophages (BMDMs) generated from WT, Trex1+/− and Trex1−/− mice 
and found that only Trex1−/− cells were resistant to VSV infection (Fig. 1g, h).
We next examined whether VSV entry is inhibited in Trex1−/− cells. This seemed unlikely 
as Trex1−/− cells did not inhibit entry of VSV-G pseudotyped HIV11, and VSV infection 
stimulated indistinguishable levels of IFN mRNA expression in WT and Trex1−/− cells (Fig. 
1a). Nonetheless, to rule out the possibility of an entry defect, we labeled wild type VSV 
virions with a fluorescent dye DiL and followed the infection of VSV-DiL in WT and 
Trex1−/− cells by live cell fluorescence microscopy (Supplementary Fig. 1a). We observed 
no differences in intracellular VSV-DiL comparing WT and Trex1−/− cells at 1 hpi. We also 
observed similar levels of VSV G and M RNA at 1 hpi in both cell types (Supplementary 
Fig. 1b). These data suggest that VSV replication was blocked at an early stage post entry, 
such as uncoating or RNA replication, in Trex1−/− cells. We also found that in contrast to 
infected WT cells, VSV infected Trex1−/− cells did not show detectable cytopathic effects 
(Supplementary Fig. 2), consistent with the notion that Trex1−/− cells were protected against 
viral infection.
To investigate whether Trex1 is also required for VSV replication in human cells, we 
infected WT and TREX1R114H/R114H (TREX1-mutant) skin fibroblasts from an AGS patient 
with VSV or VSV-PeGFP and measured levels of viral RNA. Arginine 114 is a critical 
residue at the interface of the Trex1 dimer, and the R114H mutation severely disrupts Trex1 
function in vitro22. R114H represents the most common Trex1 mutation in patients with 
AGS, and has also been associated with SLE14. Both VSV and VSV-PeGFP infection was 
decreased in TREX1R114H/R114H cells compared to WT cells, as reflected by reduced levels 
of viral RNA, reduced amounts of viral proteins, and reduced numbers of viral replication 
foci (Fig. 1i–k). Taken together, we conclude that VSV replication is impaired at an early 
post entry step in both mouse and human cells lacking Trex1 function.
Trex1 deficient cells display broad antiviral resistance
To determine whether the replication block in Trex1−/− and TREX1R114H/R114H cells was 
unique for VSV, we infected WT and Trex1−/− MEFs or WT and TREX1R114H/R114H human 
fibroblasts with three additional RNA viruses that contain either positive- or negative-
stranded genomes, and measured levels of viral RNA, amounts of viral proteins, and viral 
titers in the supernatant. All three viruses, namely influenza virus (A/WSN/1933 strain), 
Sendai virus (SeV) and West Nile virus (WNV/TX02 strain), failed to replicate efficiently in 
Trex1−/− or TREX1R114H/R114H cells compared to WT cells (Fig. 2). These results 
demonstrate that cells lacking Trex1 function are resistant to infection with several different 
types of RNA viruses.
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Trex1 regulates IFN-independent activation of ISGs
Next, we investigated the mechanism of antiviral resistance in Trex1−/− cells. We first 
examined gene expression profiles by isolating total RNA from WT or Trex1−/− MEFs that 
were mock-infected or infected with VSV, influenza virus, Sendai virus or West Nile virus, 
and performed RNA-SEQ analysis, which offers quantitative measurement of both host and 
viral RNAs simultaneously (Fig. 3a). Gene expression fold-change values validated by 
qPCR were remarkably similar to those from RNA-SEQ (Fig. 3b, Supplementary Fig. 3, 
data not shown), which underscores the quantitative power of our RNA-SEQ analysis. We 
first analyzed gene expression profiles of uninfected WT and Trex1−/− samples by Ingenuity 
Pathway Analysis (IPA) and found that the most enriched gene network in Trex1−/− cells 
compared to WT cells is ‘antimicrobial response, inflammatory response, infectious 
diseases’ consisting mostly of ISGs (Supplementary Fig. 5a,b). ‘Interferon signaling’ and 
‘cytosolic pattern recognition receptors’ are also among top ranked canonical pathways with 
high ‘hit ratio’ (determined by the percentage of genes in a pathway that are represented in a 
dataset, Supplementary Fig. 5c). We then constructed a heatmap of genes involved in 
‘antimicrobioal response’ network based on expression values and standard deviations of 
each gene across all samples (Fig. 3a). All four RNA viruses replicated less efficiently in 
Trex1−/− cells (Fig. 3a lower panel, Supplementary Fig. 4), with values ranging from 4–22% 
of those observed in WT cells. We also found that many ISGs, such as Ifit1, Ifit3 Isg15, 
Zbp1, and Usp18, were highly induced in uninfected Trex1−/− cells (Fig. 3b, Supplementary 
Fig. 3). Remarkably, uninfected Trex1−/− cells display an ISG activation signature that 
resembled infected WT cells (Supplementary Fig. 6), suggesting that the lack of Trex1 
function alone is enough to initiate an antiviral state. The establishment of this antiviral state 
appeared to be independent of IFN, because we did not detect any activation of IFN genes or 
IFN proteins (Fig. 3c, Supplementary Fig. 3). Moreover, Ifnb mRNA induction patterns by 
different viruses were indistinguishable between WT and Trex1−/− cells (Fig. 3d; influenza 
virus is known to inhibit IFN activation23). In contrast, Ifit1 mRNA was low in WT cells and 
increased after viral infection, whereas Trex1−/− cells started with very high Ifit1 (that 
appeared to be at a level that is equivalent to that observed in infected WT cells), and it 
remained high after viral infection (Fig. 3e). Trex1−/− cells treated with increasing dose of 
recombinant IFN-β showed further increase of Ifit1 expression, suggesting that Trex1−/− 
cells are capable of responding to IFN signaling (Supplementary Fig. 7). ISGs that were 
highly induced by Trex1 deficiency such as IFIT family members have intrinsic antiviral 
activity against RNA viruses24,25. Of note, not all known ISGs are activated in Trex1−/− 
cells; IFITM family members were expressed at similar amounts in WT and Trex1−/− cells 
(Supplementary Fig. 3). Together, our data suggested that a subset of ISGs are activated at 
very high levels in Trex1−/− cells independently of the IFN response.
To further confirm that the ISG activation is specific to the loss of Trex1 function, we 
knocked down Trex1 expression in WT MEFs using three different siRNAs and observed 
that the expression of Ifit1, Ifit3 and Irf7 (also an ISG) were increased significantly while the 
expression of Ifitm3, Ifna4 and Ifnb1 were not increased (Fig. 3f). We also knocked down 
Trex1 expression in Ifnar−/− MEFs and observed a similar increase in Ifit1 and Irf7 
expression (Fig. 3g), further suggesting that the ISG activation regulated by Trex1 is IFN-
independent. To determine whether the ISG activation or the IFN pathway contributed to 
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viral infection control in Trex1−/− cells, we transfected WT and Trex1−/− cells with a 
control siRNA or a specific siRNA against two ISGs (IFIT1 and IFITM3) or two key 
components of the IFN signaling pathway (STAT1 and STAT2). We then infected cells with 
VSV-PeGFP and measured infectivity by FACS (Fig. 3h). The knockdown of IFIT1 and 
IFITM3 in Trex1−/− cells partially alleviated the block in VSV replication, consistent with 
their known antiviral functions24–26. In contrast, STAT1 or STAT2 knockdown had no 
effect on VSV replication, further demonstrating that the IFN response is not required for 
control of viral infection in Trex1−/− cells. To determine whether this ISG-induction 
signature occurs in primary immune cells and tissues from Trex1−/− mice, we isolated total 
RNA from whole spleen, heart and BMDMs from WT, Trex1+/− and Trex1−/− mice and 
measured Ifit1, Irf7 and Ifnb mRNA levels. We observed up to 30-fold induction of ISGs in 
whole tissues and up to 60-fold induction of ISGs in primary immune cells only in Trex1−/− 
mice compared to WT mice (Fig. 3i). We also observed very low levels of Ifnb expression in 
all samples from Trex1−/− mice (Fig. 3i), consistent with a previous report where IFN 
expression was restricted to a subset of heart muscle cells12.
We also performed RNA-SEQ to analyze total RNA from uninfected WT or AGS patient 
fibroblasts carrying mutations in TREX1 (R114H/R114H), or AGS causing genes including 
RNASEH2C (D39Y/D115fs) or SAMHD1 (R290H/Q548X)27. We again found strong up-
regulation of a subset of ISGs, but not IFN genes, in TREX1R114H/R114H cells (Fig. 4a). 
Interestingly, the ISG activation signature was weak in RNASEH2C mutant cells and not 
present in SAMHD1 mutant cells (Fig. 4a). To determine whether the same group of ISGs 
are activated in Trex1−/− and TREX1R114H/R114H cells, we selected 35 ISGs that are 
expressed in both mouse and human cells, and compared their induction in Trex1−/− versus 
TREX1R114H/R114H cells. ISGs that were induced in Trex1−/− MEFs were also induced in 
TREX1R114H/R114H fibroblasts, with a correlation r-squared value of 0.49 (Fig. 4b). We 
observed a weak correlation between gene induction in Trex1−/− versus 
RNASEH2CD39Y/D115fscells (r2=0.14) and no correlation in Trex1−/− versus 
SAMHD1R290H/Q548X cells (r2=0.04). Our data demonstrated that Trex1 also regulates ISG 
activation in human fibroblasts.
IFN-independent ISG activation requires STING, TBK1, IRF3 and IRF7
We next wanted to identify innate immune factors that are required for IFN-independent 
ISG activation in Trex1− deficient cells. We chose to measure Ifit1 mRNA as an example of 
Trex1-regulated ISGs because it is the most highly up-regulated mRNA by Trex1 
deficiency. We first examined IRF3, which activates ISG directly9,28. We measured Ifit1 
mRNA in WT, Trex1−/− and Trex1−/−Irf3−/− MEFs, and found that Ifit1 is induced in 
Trex1−/− single knockout cells and the induction was inhibited by Trex1−/−Irf3−/− double 
knockout, suggesting that IRF3 is required for Ifit1 activation (Fig. 5a). To determine 
whether IRF3 is also required for antiviral activity in the setting of Trex1 deficiency, we 
infected WT, Trex1−/− and Trex1−/−Irf3−/− MEFs with VSV or SeV, and measured viral 
proteins by western blot or FACS analysis (Fig. 5b, c, d). Both VSV and SeV infections 
were inhibited in Trex1−/− cells, and both were restored to close to wild-type levels in 
Trex1−/−Irf3−/− cells. Therefore, IRF3 is a key component of antiviral resistance in 
Trex1−/− cells. We next wanted to explore which innate immune pathway upstream of IRF3 
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is involved. IRF3 is activated mostly by cytosolic DNA or RNA sensing pathways that are 
mediated by STING-TBK1 or RIG-I-MAVS, respectively. Therefore, we knocked down key 
components of each pathway by siRNAs in Trex1−/− cells, and measured Ifit1 expression. 
The knockdown of IRF3, IRF7, TBK1, STING, IFI204 significantly reduced Ifit1 
expression, whereas RIG-I and MAVS knockdown had no effect (Fig. 5e). We also did not 
observe any effect on Ifit1 expression in Trex1−/− cells by knocking down TLR7 or TLR9 
(data not shown). IRF3, IRF7 and TBK1 knockdown also decreased the VSV replication 
block in Trex1−/− cells (Fig. 5f). These results suggest that the cytosolic DNA, but not 
RNA, sensing machinery, is required for IFN-independent ISG activation in Trex1-deficient 
cells. STING knockdown did not appear to increase VSV replication in Trex1−/− cells, 
likely because the VSV replication assay measures the entire life cycle of VSV and many 
host factors may contribute to it, or because STING also regulates many other genes8 that 
could be required for VSV replication. The same cytosolic DNA sensing pathway is also 
involved in the activation of IFN genes during viral infection2,11, which can then activate 
ISGs. Therefore, we performed double knockdowns of Trex1 plus components of the 
cytosolic DNA sensing pathway in Ifnar−/− MEFs. Ifit1 expression was increased by Trex1 
knockdown, and this increase was reduced by further knockdown of TBK1, IRF7 OR 
STING (Fig. 5g). Trex1 knockdown in Ifnar−/− MEFs also inhibited VSV replication, and 
further knockdown of TBK1 or IRF7 alleviated that inhibition (Fig. 5h). Taken together, our 
data suggest that the core cytosolic DNA sensing machinery, STING-TBK1-IRF3-IRF7, is 
involved in activating ISGs directly in cells with reduced or no Trex1 activity.
Trex1 regulates lysosomal biogenesis through TFEB and mTORC1
We next wanted to identify the underlying basis for ISG activation in Trex1−/− or 
TREX1R114H/R114H cells. We first considered the possibility that Trex1 directly inhibits the 
cytosolic DNA sensing machinery. To test this, we used 293T cells, in which the 
overexpression of STING induced a 6-fold increase in levels of Ifit1 mRNA (Supplementary 
Fig. 8). We then co-expressed STING and increasing amounts of Trex1 to examine whether 
Trex1 overexpression inhibits STING-mediated IFIT1 activation. We did not observe any 
effect on Ifit1 induction by overexpressing Trex1 (Supplementary Fig. 8). The same level of 
Trex1 overexpression inhibited HIV-mediated activation of IFN genes11. These results 
suggest that Trex1 does not directly inhibit the cytosolic DNA sensing machinery.
We then hypothesized that perhaps accumulation of self-ligands or any cellular abnormality 
in Trex1−/− or TREX1R114H/R114H cells could be detected by the STING-TBK1-IRF3-IRF7 
pathway. We first looked at the abundance and morphology of cellular organelles, 
comparing WT and Trex1−/− cells, by immunofluorescence staining using well-defined 
organelle markers (Fig. 6a). We did not observe great differences in mitochondria, Golgi, 
ER, and early endosomes. However, late endosomes (identified by anti-LAMP1 staining) 
and lysosomes (identified by LysoTracker staining) appeared to be more abundant in 
Trex1−/− cells compared to WT cells (Fig. 6a). Similar increase in the late endosome/
lysosome compartment was also observed in Trex1−/− BMDMs, but not WT or Trex1+/− 
BMDMs (Fig. 6b). To examine if this is also observed in human cells, we stained WT and 
TREX1R114H/R114H human fibroblasts, or control and Trex1 knockdown (by siRNAs) HeLa 
cells with LysoTracker; in both cases, we observed a marked increase in LysoTracker 
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staining (Fig. 1c, Supplementary Fig. 9), indicating that the late endosome/lysosome 
compartment is expanded in cells that lack Trex1 function. We quantified lysosome 
expansion by LysoTracker FACS using live cells; Trex1−/− and TREX1R114H/R114H cells 
contained 3–5 fold more lysosomes compared to WT cells (Fig. 6d). We also detected 
increased LAMP1 and NPC1 (lysosomal membrane proteins) protein level in 
TREX1R114H/R114H and Trex1−/− cells compared to WT cells by western blot (Fig. 6e), 
suggesting enhanced lysosomal biogenesis in Trex1 deficient cells. To further confirm the 
increase in the lysosome compartment, we analyzed WT and Trex1−/− cells by electron 
microscopy (EM). Trex1−/− cells contained significantly more lysosome vacuolar structures 
(Fig. 6f,g). These structures are surrounded by single-layer membranes, some of which 
contain electron dense cellular materials that are commonly found in lysosomes (Fig. 6f 
inset). Lysosomes are important organelles for the breakdown and turnover of other cellular 
organelles (e.g. mitochondria), proteins and nucleic acids29. Of note, we did not observe 
excessive accumulation of undigested cellular materials in these lysosomes, which were 
often found in cells associated with lysosomal storage diseases30. We also did not detect an 
increase in autolysosomes in Trex1−/− cells compared to WT as measured by EM, GFP-LC3 
dot formation and by western blots analyzing p62 and LC3 protein levels (Supplementary 
Fig. 10, data not shown).
To determine whether the lysosome expansion phenotype in Trex1−/− cells was caused by 
the induction of lysosome genes, we measured Ctsa, Sgsh, Lamp1, Mcoln1 and Tpp1 
expression which encode enzymes or structural proteins of the lysosome. All five genes 
were up-regulated 3–5 fold in Trex1−/− cells compared to WT cells, whereas other non-
lysosomal genes did not (Fig. 7a). Many other genes involved in lysosomal biogenesis were 
also up-regulated in Trex1−/− cells compared to WT cells (Supplementary Fig. 11). 
Lysosome genes are regulated by the transcription factor EB (TFEB) through the 
recognition of conserved binding sites in their promoters. TFEB is a master regulator of the 
Coordinated Lysosomal Expression and Regulation (CLEAR) gene network31; and its 
overexpression increases lysosome gene expression and promotes lysosome expansion32. 
TFEB resides mostly in the cytoplasm and translocates into the nucleus upon complex post-
translational modifications33,34. We did not observe any difference in TFEB mRNA or 
protein amounts in WT and Trex1−/− cells (Fig. 7a, data not shown). To examine the 
subcellular localization of TFEB, we stained WT and Trex1−/− cells with anti-TFEB and 
found that endogenous TFEB became predominately nuclear in Trex1−/− cells (Fig. 7b). 
This result strongly suggests that the increase in lysosomal gene expression and lysosomal 
compartment expansion were connected to altered TFEB localization in Trex1−/− cells. We 
did not detect any interaction between Trex1 and TFEB by immunoprecipitation from WT 
MEFs (data not shown), suggesting Trex1 is unlikely to regulate TFEB translocation 
through direct binding and retention in the cytosol.
To examine whether TFEB function is required for ISG activation and antiviral activity in 
Trex1−/− cells, we knocked down TFEB expression in Trex1−/− cells and measured Ifit1 and 
Ifit3 mRNA in uninfected cells, and VSV replication in the same knockdown cells. TFEB 
knockdown in Trex1−/− cells reduced both Ifit1 and Ifit3 expression and increased VSV 
replication (Fig. 7c, d, e). Knockdown of TFEB in WT MEFs did not affect Ifit1 or other 
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innate immune genes that were predicted to be TFEB targets31, suggesting that TFEB is 
unlikely to regulate ISGs directly (Supplementary Fig. 12). Moreover, We found that 
Trex1−/−Irf3−/− cells express elevated levels of lysosome genes and LAMP1 protein similar 
to that in Trex1−/− cells, while ISG expression is drastically reduced in Trex1−/−Irf3−/− cells 
compared to Trex1−/− cells, suggesting that lysosomal biogenesis (regulated by TFEB) acts 
upstream of ISG expression (regulated by IRF3/7, Supplementary Fig. 11).
TFEB overexpression promotes lysosomal biogenesis32. To examine whether manipulating 
TFEB expression or nuclear translocation in WT cells also induces ISG expression, we 
overexpressed TFEB in WT MEFs and found that Ifit1 expression was increased in a dose 
dependent manner (Fig. 7f). We also treated WT MEFs with chloroquine, which induces 
TFEB nuclear translocation35, and observed dose-dependent increase of Mcoln1 (a 
lysosomal gene) and Ifit1 expression (Fig. 7g). These data further support the link between 
TFEB function in lysosomal biogenesis and ISG induction. Of note, chloroquine treatment 
of Trex1−/− cells did not rescue VSV replication (Supplementary Fig. 13), likely due to its 
known antiviral effect36–38.
One of the upstream regulators of TFEB nuclear translocation is mTORC1, and inhibition of 
mTORC1 activity under many conditions promotes TFEB nuclear transport35,39. We thus 
examined mTORC1 activity in infected and uninfected WT and Trex1−/− cells. We found 
that VSV infection induces mTORC1 activity in WT MEFs, consistent with mTORC1 being 
a pro-viral factor40 (Fig. 7h). mTORC1 activity is greatly reduced in both uninfected and 
infected Trex1−/− cells compared to uninfected and infected WT cells (measured by reduced 
p-S6K, p-S6P and p-4EBP1 levels. Fig. 7h, 7i). We also knocked down mTOR with two 
independent siRNAs and found that mTOR knockdown in WT MEFs increased Ifit1 
expression (Fig. 7j). Moreover, expression of Flag-Trex1 enhanced mTORC1 activity in WT 
cells and restored mTORC1 activity in Trex1−/− cells compared to vector plasmid controls 
(Fig. 7k). Our data suggest that Trex1 is important for maintaining mTORC1 activity, and 
that reduced mTOR leads to ISG induction. Consistent with our data, reduced mTORC1 
activity has been associated with antiviral effect40. Collectively, our data suggested that 
Trex1 regulates lysosomal biogenesis through TFEB and mTORC1, and lysosomal 
biogenesis plays a critical role in innate immunity and antiviral defense (Supplementary Fig. 
14).
DISCUSSION
It is well established that IFN plays an important role in antiviral immunity. Our cells are 
equipped with an extensive network of innate immune sensing mechanisms for detecting 
invading pathogens through recognition by PRRs. When a PRR is engaged, it triggers a 
signaling pathway that often leads to the activation of IFN expression3. Infection with 
enveloped viruses also trigger an IFN-independent pathway that involves the direct 
activation by IRF3 of a subset of ISGs28. In fact, IRF3 can bind promoters of many ISGs in 
addition to IFN genes41. Promoters of IFN genes are complex (e.g. Ifnb1), containing both 
positive and negative regulatory elements for IRFs, NF-κB and AP-1, and a concerted effort 
of multiple transcription factors is often required for their stimulation. In contrast, promoters 
of many ISGs are simpler (e.g. Ifit1), and can be easily turned on by IRFs independently of 
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IFN9,41. Direct activation of antiviral genes is important for nonprofessional IFN-producing 
cells such as fibroblasts to effectively defend themselves against viral infection, or for cells 
to defend themselves against viruses that have evolved mechanisms to disrupt the IFN 
response. It is also advantageous for cells to rapidly induce some ISGs upon viral infection 
before a stronger and more sustained response can be established by IFN signaling 
pathways. A recent study of the cytosolic RNA sensing pathway provided strong evidence 
that IFN-independent activation of ISGs mediated by peroxisomal MAVS is functionally 
important for defense against RNA virus infections10.
Very little is known about whether IFN-independent activation of ISGs occurs in the 
absence of infection, and how it is regulated. Here, we identified Trex1, a cytosolic protein 
associated with the ER, as a key negative regulator of IFN-independent activation of Ifit1 
and other ISGs in uninfected cells. When the function of Trex1 is disrupted, either by 
genetic knockout in mice, or by a homozygous mutation in humans, or by siRNA 
knockdown in a variety of cell types, a subset of ISGs were activated independently of IFN, 
leading to an antiviral state. Remarkably, the ISG induction in Trex1-deficient cells is 
sustained at very high amounts and achieves an antiviral state that is comparable to that 
caused by the IFN-dependent pathway. This is in contrast to the viral infection induced IFN-
independent response in WT cells that appears to be temporary and less robust10. We have 
also challenged WT and Trex1−/− mouse cells or TREX1R114H/R114H human cells with a 
variety of RNA viruses including VSV, influenza, Sendai and West Nile virus; and they all 
failed to replicate in cells that have lost Trex1 function.
We have also identified an innate immune pathway, involving STING-TBK1-IRF3-IRF7 
that is important for the IFN-independent ISG activation in Trex1-deficient cells. STING is 
a critical adaptor protein for sensing pathogen-associated DNA or cyclic di-GMP in the 
cytosol and subsequent induction of IFN expression2,7. Our data expands the function of the 
STING-TBK1-IRF3-IRF7 pathway to include both IFN-dependent and independent 
branches as downstream pathways. A recent study also showed that STING activates 
STAT6 phosphorylation upon viral infection, which then induces chemokines such as 
CCL2, CCL20 and CCL26 and immune cell homing8. We did not observe induction of these 
chemokines in Trex1−/− or TREX1R114H/R114H cells compared to WT (data not shown). 
Together, STING, and associated innate immune factors are becoming a versatile machinery 
that can activate multiple distinct downstream pathways.
Our data also shed some light on the potential endogenous trigger of IFN-independent ISG 
activation. We found that Trex1-deficient or mutant cells contain excessive amount of 
lysosomal vacuoles and expanded lysosomal compartments as determined by 
immunofluroscence and immunoblot analysis of lysosomal markers, quantitative RT-PCR 
analysis of lysosomal genes and by electron microscopy. Consistent with elevated lysosome 
biogenesis, the master regulator of lysosome genes, TFEB translocates to become 
predominantly nuclear in Trex1−/− cells. We also found that mTORC1 activity is reduced in 
Trex1−/− cells and is restored after Flag-Trex1 expression in Trex1−/− cells, suggesting that 
Trex1 plays an important role in maintaining mTORC1 activity, which regulates TFEB 
nuclear translocation35,39. We also provided several lines of evidence to demonstrate that 
TFEB-regulated lysosomal biogenesis is functionally linked to ISG activation: TFEB 
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knockdown in Trex1 deficient cells tempered ISG activation and antiviral immunity; TFEB 
overexpression in WT cells, which promotes lysosomal biogenesis32, increased Ifit1 
expression; chloroquine treatment of WT cells, which induces nuclear translocation of 
TFEB35 and exhibits antiviral activity36–38, increased Ifit1 expression up to 15-fold; and 
mTOR knockdown by siRNA in WT cells also increased Ifit1 expression. Furthermore, 
based on our observation of elevated lysosomal genes and protein expression and lack of 
excess accumulation of undigested contents, Trex1−/− cells are likely to have enhanced 
lysosomal function. One could imagine that the release of abnormally high amounts of 
processed peptide or nucleic acids into the cytosol, or into the extracellular space (via 
exocytosis42), might break cellular homeostasis or immune tolerance or exceed the threshold 
for cytosolic DNA sensing. The exact identity of these cytosolic DNA remains unclear, and 
previous studies have indicated DNA replication debris20 and endogenous retroelements19. 
Aberrant functions of lysosomes have been indicated in lupus nephritis where lysosomal 
contents mimic viral particles and activate innate immunity43. It is also possible that 
increased lysosome vacuoles could cause membrane perturbation that would elicit IFN-
dependent or -independent antiviral response9,44. Further studies are required to distinguish 
these possibilities. Together, our work demonstrate an important link between lysosomal 
biogenesis and innate immune activation of ISGs, as well as a novel role for TREX1 in 
regulating lysosomal biogenesis through TFEB and mTORC1.
We have previously shown that Trex1 inhibits HIV-mediated IFN activation11. Here, we 
validated this finding, and further uncovered a novel function of Trex1 in the regulation of 
IFN-independent innate immune activation through lysosomal biogenesis in uninfected 
cells, which results in a broad-spectrum antiviral state in which the replication of several 
different RNA viruses is inhibited. Both functions of Trex1 share a similar innate immune 
signaling pathway that involves STING-TBK1-IRF3, which can activate multiple 
downstream pathways. The upstream stimuli for HIV-mediated IFN activation is HIV DNA 
from nonproductive reverse transcription11, whereas the upstream stimuli for the IFN-
independent pathway likely involves lysosome function.
Our work also provides further insight into pathogenetic mechanisms underlying systemic 
autoimmunity associated with TREX1 mutation such as SLE, a prototypic autoimmune 
disease. Central to SLE pathogenesis is that ineffective waste disposal due to impaired 
apoptosis or defective clearance of cellular debris leads to excessive release of autoantigens 
which activate innate immune sensors and trigger immune responses leading to formation of 
autoantibodies45. Our findings unravel a novel mechanism for a cell-intrinsic mechanism of 
initiation of autoimmunity due to enhanced lysosome function. Moreover, the constitutive 
type I IFN-independent ‘ISG-signature’ which is detectable in a variety of cell types and 
tissues may potentially represent a valuable biomarker that could be applied as clinical 
outcome measure.
In summary, our study uncovered a signaling cascade that involves the biogenesis of a 
cellular organelle (e.g. lysosome) and cytosolic innate immune detection. Both segments of 
the cascade function together to establish an antiviral state in Trex1-deficient cells 
independently of IFN activation or viral infection. We identified many components of this 
cascade, some of which (e.g. TFEB and mTORC1) have not been directly implicated in 
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intrinsic antiviral immunity. We have also uncovered novel functions of known innate 
immune regulators such as Trex1 and STING. Further understanding of the mechanism by 
which this signaling cascade is regulated will have important implications not only for 
understanding antiviral defense but also pathogenic mechanisms underlying autoimmune 
diseases.
METHODS
Cells and viruses
Wild-type, Trex1−/− and Trex1−/−Irf3−/− MEFs and Trex1+/− mice were provided by D. 
Stetson (U. Washington) under an agreement with D. Barnes and T. Lindahl. Ifnar−/− MEFs 
were provided by Z. Chen (UT Southwestern). HeLa and 293T cells have been described11. 
All cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) with 10% (v/v) 
heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, 10 mM HEPES and 1 mM 
sodium pyruvate (complete DMEM) with the addition of 100 U/ml penicillin, 100 mg/ml 
streptomycin and cultured at 37°C with 5% CO2. WT and AGS human fibroblasts were 
derived by surgical removal of a piece of skin tissue from healthy donors or AGS patients 
with indicated mutations, and subsequently cultured in DMEM with 10% (v/v) FCS. For 
generation of bone marrow-derived macrophages, femurs and tibias were harvested from 8 
to 10 weeks old mice. Bone marrow was flushed from the bones with cold DMEM 
supplemented with 20% L-929 cell-conditioned medium, 10% (v/v) heat-inactivated FCS, 2 
mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 
mg/ml streptomycin. Bone marrow cells were cultured in 10-cm petri dishes (10 ml vol) at 
37°C, 5% CO2 for 7 d. At days 3 and 6, fresh medium was added to the cultured cells. 
Experiments involving human and mouse materials were approved by the Institutional 
Review Boards of UT Southwestern Medical Center, Dallas, Texas, USA and the Children’s 
Hospital, Technical University Dresden, Dresden, Germany. WT VSV21, VSV-PeGFP21, 
influenza virus40, Sendai virus46, West Nile virus47 were generated as described. Cells were 
infected with the indicated virus, MOI and time points and washed three times with 1X PBS 
before subsequent analysis. Experiments carried out in BSL2 and BSL3 conditions were 
approved by the Environmental Health & Safety Committee at UT Southwestern Medical 
Center.
Reagents and antibodies
Reagents: TRI Reagent, MG132, 3-MA, NH4Cl, Chloroquine, Wortmannin, Rapamycin 
(Sigma), Lipofectamine 2000, Vybrant Dil Cell labeling solution, Lysotracker (Invitrogen), 
mouse interferon ELISA kit (PBL interferon source), recombinant mouse interferon β 
(Millipore). Antibodies: mouse anti-Trex1 (mouse; 1:1,000 dilution; 29; 611987; BD 
Biosciences), anti-HMGB1 (rabbit; 1:2,000 dilution; ab18256; Abcam), anti-LAMP1 
(rabbit; 1:500 dilution; ab24170; Abcam), anti-SQSTM1/p62 (mouse; 1:1,000 dilution; 
ab56416; Abcam), anti-LC3 (rabbit; 1:500 dilution; NB100-2220; Novus Biologicals), anti-
NPC1 (rabbit; 1:1,000 dilution; # 3878-1, Epitomics), anti-Tubulin (mouse; 1:2,000 dilution; 
B-5-1-2; Sigma), α-VSV (rabbit; 1:4,000 dilution; R4006-F, kind gift from M. Whitt, 
University of Tennessee Health Science Center, Memphis, TN), anti-TFEB (rabbit; 1:2,000 
dilution; generated in house), anti-Influenza A (goat; 1:250 dilution; B65141G, Meridian 
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Life sciences), anti-Sendai (rabbit; 1:2,000 dilution; PD029, MBL), anti-WNV (rabbit; 20ug 
total; C19367, Lifespan Biosciences), anti-mTOR (7C10) (rabbit; 1:1,000 dilution; #2983; 
Cell Signaling), anti-S6 ribosomal protein (5G10) (rabbit; 1:1,000 dilution; #2217; Cell 
Signaling), anti-phospho-S6 ribosomal protein (Ser235/236) (rabbit; 1:1,000 dilution; 
#2211; Cell Signaling), anti-phospho-p70 S6 kinase (Thr389) (rabbit; 1:1,000 dilution; 
#9205; Cell Signaling), anti-phospho-4E-BP1 (Thr37/46) (rabbit; 1:1,000 dilution; #2855; 
Cell Signaling), anti-4E-BP1 (rabbit; 1:1,000 dilution; #9644; Cell Signaling) and secondary 
antibodies (1:4,000 dilution; GE Healthcare) were used for immunoblot analysis according 
to standard protocols.
RNA isolation, qRT-PCR analysis and Cytokine detection assay
Total RNA from different mouse tissues was extracted with the RNeasy Mini kit (Qiagen, # 
74104) and total RNA from cells was isolated using TRI Reagent (Sigma) according to the 
manufacturer’s instructions. RNA quantity and quality were confirmed using a NanoDrop® 
ND-1000 Spectrophotometer. cDNAs were synthesized from 1 μg total RNA using 
SuperScript® III First-Strand Synthesis (Invitrogen). Real-time PCR was performed using 
the Power SYBR Green PCR master mix in an ABI-7500 fast real-time PCR machine 
(Applied Biosystems) with specific gene primers (sequences, Supplementary Table 1, 
Sigma) and values are presented relative to GAPDH mRNA. Mouse IFN-β protein in culture 
supernatants was measured by ELISA (42400-1; PBL interferon source) according to the 
manufacturer’s recommendations.
RNA-SEQ and data analysis
Total RNA was isolated from cells using Trizol. The quality of RNA was determined to be 
RIN=8 or higher by Bio-Analyzer. One microgram of total RNA was used for producing 
RNA-SEQ cDNA library using standard protocols that include cDNA synthesize, 
fragmentation, adding adaptors, size selection, amplification and QC (Illumina). SE50 pair-
ended sequencing was done using HI-SEQ 2000 (Illumina) with > 18,000,000 reads/sample. 
Basic data analysis was done using CLC-Biosystems Genomic Workbench analysis 
programs to generate quantitative data for all genes, including RPKM values, unique and 
total gene reads, annotated transcripts and detected transcripts, median coverage, 
chromosomal location, and putative exons. Uninfected WT and Trex1−/− dataset were 
analyzed by Ingenuity Pathway Analysis software package (Ingenuity Systems, Inc). Heat 
maps were produced by first normalizing RPKM values of each gene by average and 
standard deviation across all treatment conditions, and then hierarchy-clustered heat maps 
were generated using Spotfire software.
Immunostaining, fluorescence microscopy and FACS
Cells grown on coverslips were fixed in 4% (wt/vol) paraformaldehyde and were 
permeabilized and stained by standard protocols. Samples mounted in Vectashield mounting 
medium containing DAPI (4,6-diamidino-2-phenylindole; Vector Laboratories) were 
imaged with a Zeiss Imager.M2 fluorescence microscope equipped with AxioVision 
software. The following antibodies were used for immunostaining; Anti-HSP60 (Santacruz, 
13966), anti-GM130 (BD, 610822), anti-calreticulin (Abcam, Ab4-100), anti-EEA1 
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(Abcam, ab), anti-LAMP1 (Abcam, ab24170), anti-TFEB (generated in house) with Alexa 
Fluor 488 and 546 tagged secondary antibodies (Invitrogen, A21202, A21206, A10036 and 
A10040). Live cell fluorescence microscopy was done by growing cells in 35 mm glass 
bottom dish and imaging with a Zeiss LSM510 confocal microscope. For visualizing VSV 
infection in live cells, VSV was incubated with 2 mM Vybrant Dil Cell labeling solution 
(Invitrogen) in PBS for 10 min, followed by Quick Spin Sephadex G-50 column (Roche) 
purification to remove residual dye. Labeled VSV-DiL virions were subsequently added to 
target cells, incubated for 1 h before imaging. In some experiments, LysoTracker Green was 
used to visualize lysosomes in cells with red-labeled virus. For FACS analysis of lysosomes 
or VSV-PeGFP-infected cells, cells were incubated with LysoTracker Red (40 nmol/ml for 1 
hour) or VSV-PeGFP for indicated time point. Cells were then washed 2 times with PBS 
and fixed with 1% paraformaldehyde. Cell acquisition was performed in a FACS Calibur 
(BD Biosciences). For all samples, 20,000 events were computed and analyzed by FlowJo 
software.
Transfections and western blot analysis
Cells were grown on 24-well plates and transfected with 50 nM siRNA (sequences, 
Supplementary Table 2. Sigma) using Lipofectamine 2000 (Invitrogen) according to 
manufacturer’s instruction. Cells were harvested after 48–72 h and used for infection, or 
processed for qRT-PCR or western blot analysis. Plasmid transfections were done with 
Lipofectmine 2000 (Invitrogen) or with Lonza Amaxa nuclearfector according to 
manufacture’s instructions. For western blot analysis, cells were washed with ice-cold PBS 
and lysed with 100 μl of 1X SDS-PAGE reduced sample buffer. Lysates were incubated at 
95°C for 5 min prior to resolving by 10% SDS-PAGE. Proteins were transferred to 
nitrocellulose membranes and immunoblotted with the indicated antibodies. Bands were 
visualized using either the ECL detection reagent (Pierce) or Supersignal West Pico 
Chemiluminescence western blotting detection system (Thermo Scientific, Rockford, IL) 
and exposed to X-ray film. Films were scanned and images were assembled in Photoshop.
Electron Microscopy
Wild-type, Trex1−/− MEFs were washed with PBS and fixed in 2% glutaraldehyde (in 0.1 M 
phosphate buffered saline) for a minimum of 4 hours and post-fixed in 1% osmium tetroxide 
(in 0.1 M phosphate buffered saline) for 1 hour. After rinsing and dehydrating with graded 
ethanol solutions (50%, 70%, 95%, 100%), the specimens were infiltrated sequentially with 
propylene oxide, 1:1 mixture of catalyzed Eponate 12:propylene oxide, and 100% catalyzed 
Eponate 12. The specimens were then embedded in embedding molds and polymerized in a 
60 °C oven overnight. Thick sections (1.0–1.5 micron) were cut on Leica Ultramicrotome 
with a glass knife, mounted on glass slides, and stained with toluidine blue stain. Thin 
sections (60–90 nm) were cut using a Leica Ultramicrotome with a diamond knife, mounted 
on copper grids, and stained with uranyl acetate and lead citrate. Ultrastructural examination 
was performed on a Hitachi H-7500 Transmission Electron Microscope.
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Statistical methods
Data are presented as the mean ± s.d. Statistical significance was determined by Student’s t-
test. P values of less than 0.05 were considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
VSV replication is impaired in Trex1 deficient cells. (a) Quantitative RT-PCR analysis of 
IFN-β mRNA in wild type (WT, black bars) and Trex1−/− MEFs (red bars) infected with 
VSV-G pseudotyped HIV-GFP11 or with VSV at an MOI of 2 for 24 h. AU, arbitrary units. 
ND, not detectable (b–c) Quantitative RT-PCR analysis of VSV G and M RNA (b), western 
blot analysis of VSV proteins (c) and virus titers in the supernatants (d) of WT and Trex1−/− 
MEFs mock-infected or infected with VSV for 18 h. (e, f) Fluorescence activated cell 
sorting (FACS) (e) and fluorescent microscopic (f) analysis of WT and Trex1−/− MEFs 
infected with VSV-PeGFP21 for 18 h. (g, h) fluorescent microscopic (g) and quantitative 
RT-PCR analysis of VSV G and M RNA (h) in WT, Trex1+/− and Trex1−/− MEFs infected 
with VSV-PeGFP (g) or VSV (h) for 18 h. (i, j) Quantitative RT-PCR analysis of VSV G 
and M RNA (i) and western blot analysis of VSV proteins (j) in WT and TREX1R114H/R114H 
primary human skin fibroblasts (TREX1-mutant, isolated from a healthy donor or from an 
AGS patient, respectively) at varying times post infection (0–18 hpi). Arrowhead, a non-
specific band. (k) Fluorescent microscopic analysis of WT and TREX1R114H/R114H cells 
Hasan et al. Page 18
Nat Immunol. Author manuscript; available in PMC 2013 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
infected with VSV-PeGFP for 18 h. Data are representative of at least three independent 
experiments (error bars, s.d.).
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Figure 2. 
Trex1 deficient cells display broad antiviral resistance. (a–c) Quantitative RT-PCR analysis 
of influenza NS1 RNA (a), western blot analysis of influenza proteins (b) and viral titers in 
the supernatants (c) of WT and Trex1−/− MEFs or WT and TREX1R114H/R114H (TREX1-mut) 
human fibroblasts infected with influenza virus (A/WSN/1933 strain) at an MOI of 1. AU, 
arbitrary units. ND, not detectable. (d–f) Quantitative RT-PCR analysis of Sendai virus P 
RNA (d), western blot analysis of Sendai virus proteins (e) and viral titers in the 
supernatants (f) of WT and Trex1−/− MEFs or WT and TREX1R114H/R114H human 
fibroblasts infected with Sendai virus at MOI of 10. (g–i) Quantitative RT-PCR analysis of 
West Nile virus Env RNA (g), western blot analysis of West Nile virus proteins (h) and viral 
titers in the supernatants (i) of WT and Trex1−/− MEFs infected with West Nile virus 
(WNV/TX02 strain) at an MOI of 10 or 100, as indicated. Data are representative of at least 
two independent experiments (error bars, s.d.).
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Figure 3. 
IFN-independent activation of a subset of ISGs in Trex1 deficient cells. (a) A heatmap of 
selected RNA expression values measured by RNA-SEQ analysis from WT and Trex1−/− 
MEFs uninfected or infected with viruses indicated on top for 18 h. (b) Quantitative RT-
PCR validation of IFIT family gene expression in uninfected WT and Trex1−/− MEFs. (c) 
Mouse IFN-β protein measured by ELISA in supernatants from WT and Trex1−/− MEFs 
uninfected (‘Media’) or infected with VSV. ND, not detectable. (d, e) Quantitative RT-PCR 
validation of Ifnb1 (d) and Ifit1 (e) mRNA levels in WT and Trex1−/− MEFs mock-infected 
or infected with indicated virus. AU, arbitrary units. (f) Quantitative RT-PCR analysis of 
selected ISGs and IFN genes in WT MEFs 72 h after transfection with a control siRNA or 
Trex1-specific siRNAs. si-Ctrl was normalized to 1 in all panels. *P < 0.05 (Student’s t-
test). Data are representative of three independent experiments (error bars, s.d.). Insert 
shows western blot analysis of Trex1 knockdown. (g) Quantitative RT-PCR analysis of Ifit1 
in Ifnar−/− MEFs 72 h after transfection with a control siRNA or Trex1-specific siRNAs. si-
Ctrl was normalized to 1. *P < 0.05 (Student’s t-test). Data are representative of three 
independent experiments (error bars, s.d.). (h) FACS analysis of VSV-PeGFP replication in 
WT and Trex1−/− MEFs transfected with indicated siRNA. Cells were transfected with 
siRNA for 48 h and mock-infected or infected with VSV-PeGFP for 18 h before FACS 
analysis. Percentages of GFP positive cells are shown. *P < 0.05 (Student’s t-test). Data are 
representative of two independent experiments (error bars, s.d.). (i) Quantitative RT-PCR 
analysis of Ifit1, Irf7 and Ifnb1 mRNA in spleen, heart and BMDM isolated from WT, 
Trex1+/− and Trex1−/− mice. *P < 0.05 (Student’s t-test). Data are representative of two 
independent experiments (error bars, s.d.).
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Figure 4. 
Selective ISG activation in TREX1 mutant fibroblasts. (a) A heatmap of selected RNA 
expression values measured by RNA-SEQ analysis from skin fibroblasts isolated from a 
healthy donor (WT) or from AGS patients carrying mutations in TREX1 (R114H/R114H), 
RNASEH2C (D39Y/D115fs) or SAMHD1 (R290H/Q548X). (b) Correlation analysis of ISGs 
induced by Trex1 deficiency in MEFs versus AGS mutations in humans. Thirty-five ISGs 
that were expressed in both human and mouse cells were selected for the dot plot. Each dot 
represents a gene: the x-axis value is fold-increase in Trex1−/−MEFs compared to WT, and 
the y-axis value is fold-increase in AGS mutant cells compared to WT. r-squared values 
represent the quality of correlation observed by fitting a power trend line through all data 
points.
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Figure 5. 
IFN-independent ISG activation in Trex1 deficient cells requires STING, TBK1, IRF3 and 
IRF7. (a) Quantitative RT-PCR analysis of Ifit1 in uninfected WT, Trex1−/− and 
Trex1−/−Irf3−/− MEFs. AU, arbitrary units. (b) Western blot analysis of VSV proteins in 
WT, Trex1−/− and Trex1−/−Irf3−/− MEFs infected with VSV for 18 h. UI, uninfected. (c) 
FACS analysis of VSV replication in WT, Trex1−/− and Trex1−/−Irf3−/− MEFs infected 
with VSV-PeGFP for 18 h. (d) Western blot analysis of Sendai virus proteins in WT, 
Trex1−/− and Trex1−/−Irf3−/− MEFs infected with Sendai virus for 18 h. (e,f) Quantitative 
RT-PCR analysis of Ifit1 in uninfected (e), or FACS analysis of VSV-PeGFP infected (f) 
Trex1−/− MEFs transfected with indicated siRNA. Trex1−/− MEFs were transfected with 
indicated siRNAs for 72 h and RNA was extracted for qRT-PCR analysis (e) or infected 
with VSV-PeGFP for 18 h and analyzed by FACS (f). *P< 0.01, **P< 0.05 (Student’s t-
test). Data are representative of two independent experiments (error bars, s.d.). (g,h) 
Quantitative RT-PCR analysis of Ifit1 in uninfected (g), or FACS analysis of VSV-PeGFP 
infected (h) Ifnar−/− MEFs transfected with one or two siRNAs as indicated. *P< 0.01, 
**P< 0.05 (Student’s t-test). Data are representative of two independent experiments (error 
bars, s.d.).
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Figure 6. 
Trex1 negatively regulates lysosomal biogenesis. (a-c) Fluorescent microscopic images of 
WT and Trex1−/− MEFs (a) and BMDMs (b) stained with indicated organelle markers, WT 
and TREX1R114H/R114H (TREX1-mut) human fibroblasts stained with LysoTracker Red (c). 
(d) FACS analysis of live WT and Trex1−/− MEFs or WT and TREX1R114H/R114H human 
fibroblasts stained with LysoTracker Red. (e) Western blot analysis of lysosomal membrane 
proteins, LAMP1 and NPC1, in WT and Trex1−/−MEFs and BMDMs and WT and 
TREX1R114H/R114H (Mut) human fibroblasts (FB). (f) Electron microscopic images of WT 
and Trex1−/− MEFs. The lysosome vacuoles were surrounded by single membrane 
(arrowheads in insert). Undigested cellular materials (electron dense) were found in some 
lysosome vacuoles (arrows). N, nucleus. M, mitochondrion. L, lysosome. Scale bar, 1 μm. 
(g) Number of lysosome vacuoles in thin sections per cell. Averages of 20 cells are shown 
(error bars, s.d.). *P< 0.05 (Student’s t-test).
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Figure 7. 
Trex1 regulates lysosomal biogenesis through TFEB and mTORC1. (a) Quantitative RT-
PCR analysis of lysosomal and non-lysosomal genes in WT and Trex1−/− MEFs. (b) 
Fluorescent microscopic analysis of endogenous TFEB localization in WT and Trex1−/− 
MEFs. Right panel shows percentage of nuclear TFEB in the cell. Averages of 13 cells are 
shown (error bars, s.d.) *P < 0.05 (Student’s t-test). (c,d) Western blot analysis of TFEB 
knockdown (c) and qRT-PCR analysis of Ifit1 and Ifit3 mRNA (d) in Trex1−/− MEFs 
transfected with control or TFEB specific siRNAs. (e) FACS analysis of VSV-PeGFP 
replication in WT and Trex1−/− MEFs transfected with control or TFEB specific siRNAs for 
72 h and mock-infected or infected with VSV-PeGFP for 18 h. *P< 0.05 (Student’s t-test). 
Data are representative of three independent experiments (error bars, s.d.). (f) Quantitative 
RT-PCR analysis of Ifit1 expression in WT MEFs transfected with myc-TFEB or pcDNA3 
vector plasmid at indicated amount for 24 h. (g) Quantitative RT-PCR analysis of Ifit1 and 
Mcoln1 in WT MEFs treated with chloroquine at 10, 50 and 100 uM for 16 h. (h, i) Western 
blot (h) and densitometry (i) analysis of proteins involved in the mTORC1 pathway. WT 
and Trex1−/− MEFs were uninfected or infected with VSV for 16 h. Densitometry analysis 
was performed using Image J on 6 independent western blots. WT normalized to 1. *P< 
0.05 (Student’s t-test). Data are representative of 6 independent experiments (error bars, 
s.d.). (j) Quantitative RT-PCR analysis of Ifit1 expression in WT MEFs transfected with 
indicated siRNAs for 72 h. *P< 0.05 (Student’s t-test). Data are representative of two 
independent experiments (error bars, s.d.). (k) Western blot analysis of proteins involved in 
the mTORC1 pathway. WT and Trex1−/− MEFs were transfected with vector or Flag-Trex1 
plasmid for 24 h. A representative gel image of 4 independent experiments is shown.
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